hurriyet.com.tr / FOREIGN NEWS
As the Omicron variant of the coronavirus continues to spread rapidly, a flash statement came from the World Health Organization (WHO). The expected statement about the contagiousness of the new coronavirus variant XE seen in the UK has come.
In the Corona virus, which has not been on the agenda recently with the Omicron variant (Covid-19) there was a warm development
According to the news in NDTV, it was announced that XE is a recombinant, a mutation of BA’1 and BA.2 Omicron strains.
Recombinant mutations occur when a patient is infected with more than one coronavirus variant.
British experts said in an article published in the British Medical Journal that variants shuffle their genetic material during replication, creating a new mutation.
EXPLANATION FROM WHO
The expected statement on the subject came from the World Health Organization (WHO). WHO announced that the new mutation XE is 10 percent more contagious than the BA.2 subvariant of Omicron.
In the statement, it was underlined that research continues to reach a definite information that this result is the first finding.
HOW MANY PEOPLE HAVE THE NEW VARIANT XE SEEN?
The UK’s health agency reported that the XE variant was first detected on 19 January, with the new variant detected in 637 cases.
WHY IS OMICRON MORE CONTAGIOUS?
On the other hand, initial findings suggest that Omicron is more contagious but milder than Delta and Wuhan versions.
The lower severity of the Omicron variant is attributed to both the characteristics of this variant and the increased immunity due to vaccination and infection.
Analysis at Imperial College London shows that Omicron mutations make it a milder virus than the Delta variant.
If there is no immunity to the coronavirus, the Omicron varnata is 11 percent less likely to present to the hospital emergency department compared to the delta variant. However, this is the case for fewer people now, as the level of vaccination and infection has risen.
Considering the immune status developed in the population, the risk of hospitalization with Omicron infection decreases by 25-30 percent, while the risk of staying in the hospital for more than one day decreases by 40 percent.
From the team conducting the Imperial College research, Prof. Neil Ferguson says this is “somewhat good news.” However, he states that this decrease is not at a level that will create a big change in the modeling, and warns that the number of people applying to the hospital may still be high due to the rapid spread of Omicron, and this may put pressure on the health service.
Omicron’s lab reviews provide data on why this variant might be milder.
University of Hong Kong research has shown that while Omicron is effective at infecting the upper respiratory tract, it cannot penetrate the lung tissue where it can cause further damage.
Cambridge University studies also revealed that the Omicron variant is not as effective as other variants in gluing lung cells together. This problem usually appeared in the lungs of severely ill patients.